Publicaciones en colaboración con investigadores/as de Pfizer (United States) (5)

2017

  1. Functional PTGS2 polymorphism-based models as novel predictive markers in metastatic renal cell carcinoma patients receiving first-line sunitinib

    Scientific Reports, Vol. 7

2013

  1. Fluorouracil, leucovorin, and irinotecan plus either sunitinib or placebo in metastatic colorectal cancer: A randomized, phase III trial

    Journal of Clinical Oncology, Vol. 31, Núm. 10, pp. 1341-1347

2012

  1. A phase I study of sunitinib in combination with FOLFIRI in patients with untreated metastatic colorectal cancer

    Annals of Oncology, Vol. 23, Núm. 1, pp. 119-127

2007

  1. Safety and efficacy of sunitinib and FOLFIRI in combination in treatment-naive metastatic colorectal cancer (mCRC): a phase I study

    EJC SUPPLEMENTS

2004

  1. Prospective randomised phase III trial of etoposide/cisplatin versus high-dose epirubicin/cisplatin in small-cell lung cancer

    Clinical Lung Cancer, Vol. 6, Núm. 3, pp. 175-183